Oral pharmacotherapy for erectile dysfunction: current perspectives
Open Access
- 1 September 1999
- Vol. 54 (3) , 392-400
- https://doi.org/10.1016/s0090-4295(99)00200-9
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Sildenafil (Viagra)The Nurse Practitioner, 1998
- THE EFFECT OF THE SPECIFIC PHOSPHODIESTERASE (PDE) INHIBITORS ON HUMAN AND RABBIT CAVERNOUS TISSUE IN VITRO AND IN VIVOJournal of Urology, 1998
- Effect of oral administration of prostaglandin E1BJU International, 1997
- The ?syncytial tissue triad?: a model for understanding how gap junctions participate in the local control of penile erectionWorld Journal of Urology, 1997
- Cyclic nucleotide phosphodiesterase in human cavernous smooth muscleWorld Journal of Urology, 1997
- Signal transduction in cavernous smooth muscleWorld Journal of Urology, 1997
- Clinical Guidelines Panel on Erectile Dysfunction: Summary Report on the Treatment of Organic Erectile DysfunctionJournal of Urology, 1996
- Sildenafil, a novel effective oral therapy for male erectile dysfunctionBritish Journal of Urology, 1996
- Outcome Analysis of Goal Directed Therapy for ImpotenceJournal of Urology, 1996
- Nitric Oxide Relaxes Rabbit Corpus Cavernosum Smooth Muscle via a Potassium-Conductive PathwayBiochemical and Biophysical Research Communications, 1996